B. Riley Wealth Advisors’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

B. Riley Wealth Advisors’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$1.75K	–	1687
2023 Q1	$1.75K	Hold	10,000	–	–	﹤0.01%	1512
2022 Q4	$3.98K	Sell	10,000 -4,172	-29%	-$2.75K	﹤0.01%	1484
2022 Q3	$12K	Buy	+14,172	New	+$29.8K	﹤0.01%	1434

B. Riley Wealth Advisors's CDAK Position: Q2 2023 in Review

B. Riley Wealth Advisors sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 10,000 shares — an estimated $1.75K sold.

B. Riley Wealth Advisors first reported a position in CDAK in Q3 2022 and held it in 3 quarters. The position peaked at $12K in Q3 2022. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

B. Riley Wealth Advisors reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
B. Riley Wealth Advisors sold 10,000 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $1.75K.
B. Riley Wealth Advisors first reported a position in Codiak BioSciences, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
B. Riley Wealth Advisors's Codiak BioSciences, Inc. Common Stock position peaked at $12K in Q3 2022.
1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.